Updated:
Arcadia Biosciences Inc
Arcadia Biosciences was founded in 2002 in Davis, California, initially as a plant-science technology developer.
Arcadia Biosciences Inc
Arcadia Biosciences was founded in 2002 in Davis, California, initially as a plant-science technology developer. The company went public in 2015 on the Nasdaq under the symbol RKDA. Its wealth came from public market investors rather than a single family fortune. The firm's strategy centers on three core trait platforms: water-use efficiency, nitrogen-use efficiency, and heat tolerance — crops are engineered to yield more grain with less water or fertilizer. Arcadia does not grow or sell grain directly; it licenses its genetics to major seed companies. Known executed license agreements include a pact with Arcadia's former subsidiary, Arcadia Specialty Genomics, and a 2023 partnership with a global seed company for wheat traits. Its geographic focus spans North America, South America, and Australia. As of 2025, Arcadia employed roughly 30 full-time professionals, headquartered in Davis with a small presence in Seattle. In February 2024, the company sold its GoodWheat branded consumer products division as part of a restructuring to focus entirely on its core trait licensing business. A research partnership with the International Rice Research Institute (IRRI) was disclosed in 2023. Arcadia's structural differentiator is its pure-play trait licensing model — the firm does not operate farms, process food, or sell consumer goods. It relies on royalty-based revenue streams, which limits capital intensity but ties cash flow to its partners' adoption rates. The company has self-funded through public equity raises and grant programs, giving it a hybrid public-company governance structure rare among agtech pure plays.
General information
Firm type
other
Year founded
2002
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Davis
Corporate office
Davis, CA, United States
Principals
Stan Jacot
Chief Executive Officer
Rajiv Gangadharan
Chief Financial Officer
Sector focus
Frequently asked questions
What does Arcadia Biosciences actually do?
Arcadia develops and licenses genetic crop traits that improve water-use efficiency, nitrogen-use efficiency, and heat tolerance in staple crops like wheat and rice. It does not grow or sell grain; it earns revenue through licensing agreements with seed companies worldwide.
Does Arcadia invest in other agtech companies or operate as a family office?
No. Arcadia Biosciences is a publicly traded company (Nasdaq: RKDA) that operates as a research and licensing firm. It does not function as a family office, investment vehicle, or asset manager.
Who are Arcadia's main license partners?
Arcadia has licensed its traits to seed companies operating in North America, South America, and Australia. Specific partners include a global seed company via a 2023 wheat trait agreement and the International Rice Research Institute for rice trait development (per public disclosure, 2023).
How does Arcadia generate revenue?
The firm earns revenue primarily through upfront license fees, milestone payments, and ongoing royalties on seed sales that incorporate its traits. It has also received grant funding from agencies such as the U.S. Department of Energy.
Why did Arcadia sell its GoodWheat consumer product line?
In February 2024, Arcadia sold the GoodWheat division to simplify its business model and focus capital on its core trait licensing platform (per the firm's SEC filing, February 2024). The sale effectively ended Arcadia's direct-to-consumer food product operations.
What is the size of Arcadia's addressable market?
Arcadia targets the global market for wheat and rice seeds — wheat alone is planted on over 500 million acres annually. The firm's traits are designed for large-acre crops, making its royalty potential significant if adoption expands beyond current pilot programs (per the firm's investor materials).
Does Arcadia have any philanthropic or sustainability-linked initiatives?
Arcadia has publicly stated that its nitrogen-use efficiency and water-use efficiency traits can reduce greenhouse gas emissions and water usage in agriculture. However, the firm does not operate a separate philanthropic foundation; its impact is embedded in its commercial licensing model.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: